(TBPH) Theravance Biopharma Renko charts technical analysis
(TBPH) Theravance Biopharma Renko charts technical analysis Renko analysis of Theravance Biopharma | Buy/Sell Theravance Biopharma
Theravance Biopharma trades in USA in Health Care sector.
10 day averaged volume of Theravance Biopharma is 216550
| Date | Closing Price | Open | High | Low | Volume |
| 05 Wed Feb 2025 | 9.72 | 9.55 | 9.80 | 9.55 | 0.124 Mn |
| 04 Tue Feb 2025 | 9.43 | 9.44 | 9.54 | 9.39 | 0.099 Mn |
| 03 Mon Feb 2025 | 9.47 | 9.25 | 9.59 | 9.23 | 0.12 Mn |
| 31 Fri Jan 2025 | 9.38 | 9.68 | 9.68 | 9.27 | 0.235 Mn |
| 30 Thu Jan 2025 | 9.67 | 9.63 | 9.76 | 9.59 | 0.096 Mn |
| 29 Wed Jan 2025 | 9.63 | 9.79 | 9.79 | 9.46 | 0.109 Mn |
| 28 Tue Jan 2025 | 9.83 | 9.67 | 9.88 | 9.60 | 0.15 Mn |
| 27 Mon Jan 2025 | 9.67 | 10.46 | 10.46 | 9.62 | 0.455 Mn |
| 24 Fri Jan 2025 | 10.47 | 9.65 | 10.90 | 9.62 | 0.508 Mn |
| 23 Thu Jan 2025 | 9.67 | 9.26 | 9.68 | 9.24 | 0.174 Mn |
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.82 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.82 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.